Lv6
2998 积分 2024-11-25 加入
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
27天前
已完结
Vascular endothelial growth factor (VEGF) – a valuable serum tumour marker in patients with colorectal cancer?
1个月前
已完结
Abstract 2734: RC148, a novel bispecific antibody targeting PD-1 and VEGF for cancer immunotherapy
1个月前
已关闭
1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies
1个月前
已完结
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
3个月前
已完结
Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses
3个月前
已关闭
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
4个月前
已完结
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
4个月前
已完结
Pharmacodynamic model of tolerance: application to nicotine
5个月前
已完结
Putting Pharmacokinetics and Pharmacodynamics to Work in Drug Discovery
6个月前
已完结
皖公网安备34019202002308
